Cochlear Limited (COH.AX)
AUD 291.11
(-1.13%)
AUD 291.11
(-1.13%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.69 Billion AUD | 15.56% |
| 2023 | 1.46 Billion AUD | 19.32% |
| 2022 | 1.23 Billion AUD | 13.57% |
| 2021 | 1.08 Billion AUD | 7.46% |
| 2020 | 1 Billion AUD | -6.29% |
| 2019 | 1.07 Billion AUD | 7.29% |
| 2018 | 1 Billion AUD | 11.96% |
| 2017 | 895.4 Million AUD | 12.35% |
| 2016 | 796.95 Million AUD | 22.55% |
| 2015 | 650.31 Million AUD | 16.83% |
| 2014 | 556.65 Million AUD | 1.93% |
| 2013 | 546.13 Million AUD | -5.93% |
| 2012 | 580.57 Million AUD | -1.24% |
| 2011 | 587.89 Million AUD | 9.12% |
| 2010 | 538.74 Million AUD | 7.54% |
| 2009 | 500.97 Million AUD | 15.14% |
| 2008 | 435.08 Million AUD | 8.78% |
| 2007 | 399.95 Million AUD | 24.38% |
| 2006 | 321.55 Million AUD | 26.79% |
| 2005 | 253.6 Million AUD | 22.57% |
| 2004 | 206.9 Million AUD | -7.42% |
| 2003 | 223.47 Million AUD | 22.78% |
| 2002 | 182.01 Million AUD | 23.24% |
| 2001 | 147.69 Million AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 72.92 Million AUD | 0.9% |
| 1996 | 72.27 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 1.69 Billion AUD | 15.56% |
| 2024 Q4 | 868.5 Million AUD | 0.0% |
| 2024 Q2 | 827.6 Million AUD | 0.0% |
| 2023 Q2 | 665.7 Million AUD | 0.0% |
| 2023 FY | 1.46 Billion AUD | 19.32% |
| 2023 Q4 | 801.99 Million AUD | 0.0% |
| 2022 Q4 | 622.5 Million AUD | 0.0% |
| 2022 Q2 | 607.6 Million AUD | 0.0% |
| 2022 FY | 1.23 Billion AUD | 13.57% |
| 2021 Q2 | 533.6 Million AUD | 0.0% |
| 2021 FY | 1.08 Billion AUD | 7.46% |
| 2021 Q4 | 549.5 Million AUD | 0.0% |
| 2020 Q2 | 585.4 Million AUD | 0.0% |
| 2020 FY | 1 Billion AUD | -6.29% |
| 2020 Q4 | 422.5 Million AUD | 0.0% |
| 2019 Q2 | 524.3 Million AUD | 0.0% |
| 2019 Q4 | 551.3 Million AUD | 0.0% |
| 2019 FY | 1.07 Billion AUD | 7.29% |
| 2018 Q4 | 529.3 Million AUD | 0.0% |
| 2018 FY | 1 Billion AUD | 11.96% |
| 2018 Q2 | 473.2 Million AUD | 0.0% |
| 2017 Q4 | 462.4 Million AUD | 0.0% |
| 2017 FY | 895.4 Million AUD | 12.35% |
| 2017 Q2 | 433 Million AUD | 0.0% |
| 2016 FY | 796.95 Million AUD | 22.55% |
| 2016 Q4 | 410.14 Million AUD | 0.0% |
| 2016 Q2 | 386.81 Million AUD | 0.0% |
| 2015 Q4 | 339.33 Million AUD | 0.0% |
| 2015 Q2 | 310.97 Million AUD | 0.0% |
| 2015 FY | 650.31 Million AUD | 16.83% |
| 2014 Q2 | 247.39 Million AUD | 0.0% |
| 2014 FY | 556.65 Million AUD | 1.93% |
| 2014 Q4 | 309.26 Million AUD | 0.0% |
| 2013 Q4 | 257.79 Million AUD | 88.81% |
| 2013 Q3 | 136.53 Million AUD | 0.0% |
| 2013 Q2 | 136.53 Million AUD | -5.93% |
| 2013 Q1 | 145.14 Million AUD | 0.0% |
| 2013 FY | 546.13 Million AUD | -5.93% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q2 | 145.14 Million AUD | -1.24% |
| 2012 Q1 | 146.97 Million AUD | 0.0% |
| 2012 FY | 580.57 Million AUD | -1.24% |
| 2012 Q3 | 145.14 Million AUD | 0.0% |
| 2011 Q1 | 134.68 Million AUD | 0.0% |
| 2011 Q2 | 146.97 Million AUD | 9.12% |
| 2011 Q3 | 146.97 Million AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 587.89 Million AUD | 9.12% |
| 2010 FY | 538.74 Million AUD | 7.54% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 134.68 Million AUD | 0.0% |
| 2010 Q2 | 134.68 Million AUD | 7.54% |
| 2010 Q1 | 125.24 Million AUD | 0.0% |
| 2009 Q2 | 125.24 Million AUD | 15.14% |
| 2009 FY | 500.97 Million AUD | 15.14% |
| 2009 Q3 | 125.24 Million AUD | 0.0% |
| 2009 Q1 | 108.77 Million AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2008 Q1 | 99.98 Million AUD | 0.0% |
| 2008 Q2 | 108.77 Million AUD | 8.78% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 435.08 Million AUD | 8.78% |
| 2008 Q3 | 108.77 Million AUD | 0.0% |
| 2007 FY | 399.95 Million AUD | 24.38% |
| 2007 Q3 | 99.98 Million AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q2 | 99.98 Million AUD | 24.38% |
| 2007 Q1 | 80.38 Million AUD | 0.0% |
| 2006 FY | 321.55 Million AUD | 26.79% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q3 | 80.38 Million AUD | 0.0% |
| 2006 Q2 | 80.38 Million AUD | 26.79% |
| 2006 Q1 | 63.4 Million AUD | 0.0% |
| 2005 Q1 | 51.72 Million AUD | 0.0% |
| 2005 Q2 | 63.4 Million AUD | 22.57% |
| 2005 Q3 | 63.4 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 FY | 253.6 Million AUD | 22.57% |
| 2004 Q1 | 55.86 Million AUD | 0.0% |
| 2004 FY | 206.9 Million AUD | -7.42% |
| 2004 Q2 | 51.72 Million AUD | -7.42% |
| 2004 Q3 | 51.72 Million AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 FY | 223.47 Million AUD | 22.78% |
| 2003 Q2 | 55.86 Million AUD | 22.78% |
| 2003 Q1 | 45.5 Million AUD | 0.0% |
| 2003 Q3 | 55.86 Million AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2002 FY | 182.01 Million AUD | 23.24% |
| 2002 Q2 | 45.5 Million AUD | 23.24% |
| 2002 Q3 | 45.5 Million AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q1 | 36.92 Million AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q3 | 36.92 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 FY | 147.69 Million AUD | 0.0% |
| 2001 Q2 | 36.92 Million AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 18.23 Million AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 Q1 | 18.06 Million AUD | 0.0% |
| 1997 Q2 | 18.23 Million AUD | 0.9% |
| 1997 Q3 | 18.23 Million AUD | 0.0% |
| 1997 FY | 72.92 Million AUD | 0.9% |
| 1996 Q3 | 18.06 Million AUD | 0.0% |
| 1996 Q2 | 18.06 Million AUD | 0.0% |
| 1996 Q4 | 18.06 Million AUD | 0.0% |
| 1996 FY | 72.27 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -48118.371% |
| Adherium Limited | -640.83 Thousand AUD | 264770.313% |
| Aroa Biosurgery Limited | 53.98 Million AUD | -3041.584% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -117954.855% |
| Anteris Technologies Ltd | 2.51 Million AUD | -67280.931% |
| Control Bionics Limited | 3.67 Million AUD | -46080.328% |
| CardieX Limited | 10.1 Million AUD | -16680.172% |
| Compumedics Limited | 26.06 Million AUD | -6406.445% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -14831.353% |
| Cyclopharm Limited | 4.49 Million AUD | -37613.505% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -15017.828% |
| Nova Eye Medical Limited | 20.19 Million AUD | -8299.445% |
| HeraMED Limited | -504.09 Thousand AUD | 336564.357% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 85207.472% |
| ImpediMed Limited | 9 Million AUD | -18735.092% |
| InhaleRx Limited | 1.2 Million AUD | -140766.711% |
| LBT Innovations Limited | -2.91 Million AUD | 58245.355% |
| Micro-X Limited | 5.73 Million AUD | -29464.232% |
| Neurotech International Limited | -5867.00 AUD | 28909252.889% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -3048684.872% |
| PolyNovo Limited | 36.08 Million AUD | -4600.291% |
| Respiri Limited | 456.91 Thousand AUD | -371107.711% |
| SomnoMed Limited | 55.13 Million AUD | -2976.477% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -39482.846% |
| Uscom Limited | 3.11 Million AUD | -54337.292% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 625699.374% |